Market Research Logo

Osteoporosis Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Osteoporosis Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Osteoporosis is a bone related disease that weakens bones and increase the risk of fracture and breaking of bones. The factors responsible for osteoporosis include, long-term use of high-dose oral corticosteroids, a family history of osteoporosis – particularly history of a hip fracture in a parent, having a low body mass index (BMI), heavy drinking and smoking, and others. The prevalence of osteoporosis is high among the adult population. For instance, according to a report by National Osteoporosis Foundation in 2016, around 54 million adult in the U.S were suffering from osteoporosis or have low bone density.
Market Dynamics
Increasing approvals and launches of novel osteoporosis drugs is expected to significantly drive the osteoporosis treatment market growth over forecast period. For instance, in 2013, Pfizer Inc. received the U.S. Food and Drug Administration (FDA) approval for its drug— DUAVEETM (conjugated estrogens/bazedoxifene) 0.45mg / 20mg tablets—for the treatment of moderate-to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis. Furthermore, osteoporosis commonly affects older adults and increasing geriatric population is expected to lead to high demand for osteoporosis treatment drugs. For instance, according to a report by United Nations Population Fund, people aged 60 years and above accounted for 12.3% of the global population in 2015 and this is expected to reach 22% by 2050 that accounts for 2 billion people.
Key features of the study:

This report provides in-depth analysis of the osteoporosis treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global osteoporosis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include, EffRx Pharmaceuticals SA, Daiichi Sankyo Company, Limited, Amgen Inc., Dr Reddy\'s Laboratories, Mylan Inc., Pfenex Inc., Eli Lilly and Company, Asahi Kasei Corporation, F.Hoffmann La Roche, Teva Pharmaceutical Industries Ltd., Novartis AG, Merck & Co AG, GlaxoSmithKline Plc., Allergan plc., and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics
The global osteoporosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the osteoporosis treatment market

Detailed Segmentation:

Global Osteoporosis Treatment Market, by Drug Type :

Bisphosphonates

Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others

Calcitonin
Hormone Therapy
Selective Estrogen Receptor Modulators (SERMs)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Rank Ligand (RANKL) Inhibitor

Global Osteoporosis Treatment Market, by Route of Administration:

Oral
Injectable
Others

Global Osteoporosis Treatment Market, by Distribution Channel:

Hospitals
Online Pharmacies
Retail Pharmacies

Global Osteoporosis Treatment Market, by Geography:

North America

Drug Type:

Bisphosphonates

Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others

Calcitonin
Hormone Therapy
Selective Estrogen Receptor Modulators (SERMs)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Rank Ligand (RANKL) Inhibitor

By Route of Administration:

Oral
Injectable
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

U.S.
Canada

Europe

Drug Type:

Bisphosphonates

Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others

Calcitonin
Hormone Therapy
Selective Estrogen Receptor Modulators (SERMs)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Rank Ligand (RANKL) Inhibitor

By Route of Administration:

Oral
Injectable
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Bisphosphonates

Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others

Calcitonin
Hormone Therapy
Selective Estrogen Receptor Modulators (SERMs)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Rank Ligand (RANKL) Inhibitor

By Route of Administration:

Oral
Injectable
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

Drug Type:

Bisphosphonates

Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others

Calcitonin
Hormone Therapy
Selective Estrogen Receptor Modulators (SERMs)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Rank Ligand (RANKL) Inhibitor

By Route of Administration:

Oral
Injectable
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Middle East

Drug Type:

Bisphosphonates

Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others

Calcitonin
Hormone Therapy
Selective Estrogen Receptor Modulators (SERMs)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Rank Ligand (RANKL) Inhibitor

By Route of Administration:

Oral
Injectable
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

GCC
Israel
Rest of Middle East

Africa

Drug Type:

Bisphosphonates

Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others

Calcitonin
Hormone Therapy
Selective Estrogen Receptor Modulators (SERMs)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Rank Ligand (RANKL) Inhibitor

By Route of Administration:

Oral
Injectable
Others

By Distribution Channel

Hospitals
Online Pharmacies
Retail Pharmacies

By Country:

Central Africa
South Africa
North Africa

Company Profiles

Teva Pharmaceutical Industries Ltd.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Daiichi Sankyo Company Limited.
Amgen Inc.
Dr Reddy\'s Laboratories
Mylan Inc.
Pfenex Inc.
Eli Lilly and Company
Asahi Kasei Corporation
F.Hoffmann La Roche
EffRx Pharmaceuticals SA
Novartis AG
Merck & Co AG
GlaxoSmithKline Plc.
Allergan plc.
Pfizer Inc.

“*” marked represents similar segmentation in other categories in the respective section.


Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
PEST Analysis
Pipeline Analysis
Product Approval
Product Launch
Collaboration-Acquisition
Porter’s Five Forces Analysis
Global Osteoporosis Treatment Market, By Drug Type, 2016 – 2026 (US$ Bn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Bisphosphonates
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Segment Trends
Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others
Calcitonin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Hormone Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Selective Estrogen Receptor Modulators (SERMs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Rank Ligand (RANKL) Inhibitor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Global Osteoporosis Treatment Market, By Route of Administration, 2016 – 2026 (US$ Bn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Global Osteoporosis Treatment Market, By Distribution Channel, 2016 – 2026 (US$ Bn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
Global Osteoporosis Treatment Market, By Region, 2016 – 2026 (US$ Bn)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
GCC
Israel
Rest of Middle East
Competitive Landscape
Heat Map Analysis
Company Profiles
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Daiichi Sankyo Company Limited.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Amgen Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Dr Reddy\'s Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Mylan Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfenex Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Eli Lilly and Company
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Asahi Kasei Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
F.Hoffmann La Roche
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
EffRx Pharmaceuticals SA
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline Plc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Allergan plc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Section
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 30figures on “Osteoporosis Treatment Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report